Botulinum toxin assessment, intervention and aftercare for lower limb disorders of movement and muscle tone in adults: international consensus statement.
about
Multidisciplinary rehabilitation following botulinum toxin and other focal intramuscular treatment for post-stroke spasticityNon pharmacological interventions for spasticity in multiple sclerosisMultidisciplinary rehabilitation following botulinum toxin and other focal intramuscular treatment for post-stroke spasticityCurrent and future medical treatment in primary dystonia.Protective effect of botulinum toxin A after cutaneous ischemia-reperfusion injury.Consensus clinical management guidelines for Friedreich ataxia.Survey of Botulinum Toxin Injections in Anticoagulated Patients: Korean Physiatrists' Preference in Controlling Anticoagulation Profile Prior to Intramuscular Injection.Use of botulinum toxin type A in the management of patients with neurological disorders: a national surveyAssessing the neurophysiological effects of botulinum toxin treatment for adults with focal limb spasticity: a systematic review.Abo-, inco-, ona-, and rima-botulinum toxins in clinical therapy: a primer.The efficacy of Botulinum Toxin A for spasticity and pain in adults: a systematic review and meta-analysis using the Grades of Recommendation, Assessment, Development and Evaluation approach.The effectiveness of therapy on outcome following (BoNT-A) injection for focal spasticity in adults with neurological conditions: A systematic review.Patient Registry of Spasticity Care World: Data Analysis Based on Physician Experience.Do clinical tests of spasticity accurately reflect muscle function during walking: A systematic review.Beneficial effect of botulinum toxin A on Raynaud's phenomenon in Japanese patients with systemic sclerosis: A prospective, case series study.A prospective, multicentre, randomized, double-blind, placebo-controlled trial of onabotulinumtoxinA to treat plantarflexor/invertor overactivity after stroke.Early botulinum toxin treatment for spastic pes equinovarus--a randomized double-blind placebo-controlled study.Are gait and mobility measures responsive to change following botulinum toxin injections in adults with lower limb spasticity?The use of botulinum toxin type A in the management of adult-onset focal spasticity: a survey of Australian allied health professionals.A systematic review: efficacy of botulinum toxin in walking and quality of life in post-stroke lower limb spasticity.Interventions for managing skeletal muscle spasticity following traumatic brain injury.Friedreich's ataxia: clinical features, pathogenesis and management.Severity and distribution of spasticity does not limit mobility or influence compensatory strategies following traumatic brain injury.Parents and Physiotherapists Recognition of Non-Verbal Communication of Pain in Individuals with Cerebral Palsy.Goal Attainment Scaling in Individuals with Upper Limb Spasticity Post Stroke.Effectiveness of botulinum toxin injection with and without needle electromyographic guidance for the treatment of spasticity in hemiplegic patients: a randomized controlled trial.Intensive therapy after botulinum toxin in adults with spasticity after stroke versus botulinum toxin alone or therapy alone: a pilot, feasibility randomized trial.
P2860
Q24202197-99E8EE5B-B99B-4147-BACD-644C1FB358C7Q24202441-9B1F8E1D-D790-4FEA-869D-3B615967A44BQ24203617-DDB5BA1E-8A12-4AA7-8606-C145BDF59121Q30465848-8282E4B0-9317-47B5-9FEC-C7434F6A7BB6Q33562360-F11FEC2A-894E-42B5-85A8-335561B569AEQ34789144-6E35702B-8D6A-438B-A36B-0A56CE0E68FBQ36864584-DB51E3A9-40B8-46D1-A43A-8AA9B6AE8778Q37632889-661E2469-B325-4441-9EB2-D90CC0FB44ECQ37939194-7237AAD4-2F08-477A-9CED-424D8926AE39Q38080776-3CA2D910-ADE8-4DB8-8F1C-15D710556D74Q38122349-A028D177-112C-4356-9E9B-1ABE64F77657Q38397501-D6599F4D-6957-4F53-AB4E-8F6D1454D5B8Q38704938-CEF864E7-FA2F-4CBF-A3E6-4DC8443DD352Q38925041-F88336C7-2DCF-41EA-BC83-A0753F8E17FAQ40296383-81FC1CFF-0817-4D1F-A1B9-3F58FC1FBA82Q42635046-36E3B563-12C5-4727-9EE1-055B8F5912A7Q42656165-38AC1E52-2BC8-4613-9F59-B3FC7FDE60D6Q44497245-006B5970-D49F-4B05-87AF-EA92082B87C1Q45945324-C83DF2B4-66E5-4D80-B81F-638AA1189D5EQ47171933-A8D5CDD8-5823-461E-B046-2108AF806276Q47428698-4FAC6F0D-EA6C-4691-A6C4-E58AAA630C34Q47623823-A44E7001-FF0F-4E7F-953C-F4448D79F904Q48124904-EADAC230-1ADA-436B-933B-CE241EF3C480Q48163437-399189FC-516E-49F0-832C-07EEFDE5B26EQ48785734-90E70AD7-DCC1-4CBD-B08D-E9036AEEEEADQ50854451-E112154E-0D87-418A-BB73-373E73FCA2B2Q55009015-E56B3A68-4C7D-40B8-9B5E-063F62479E65
P2860
Botulinum toxin assessment, intervention and aftercare for lower limb disorders of movement and muscle tone in adults: international consensus statement.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on August 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Botulinum toxin assessment, in ...... rnational consensus statement.
@en
Botulinum toxin assessment, in ...... rnational consensus statement.
@nl
type
label
Botulinum toxin assessment, in ...... rnational consensus statement.
@en
Botulinum toxin assessment, in ...... rnational consensus statement.
@nl
prefLabel
Botulinum toxin assessment, in ...... rnational consensus statement.
@en
Botulinum toxin assessment, in ...... rnational consensus statement.
@nl
P2093
P2860
P1476
Botulinum toxin assessment, in ...... ernational consensus statement
@en
P2093
A Esquenazi
B J Singer
Cerebral Palsy Institute
V S C Fung
P2860
P356
10.1111/J.1468-1331.2010.03128.X
P478
17 Suppl 2
P50
P577
2010-08-01T00:00:00Z